1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

A Cautionary Tale for All Labs

Discussion in 'CSI Laboratories' started by Anonymous, Feb 28, 2013 at 3:05 PM.

  1. Anonymous

    Anonymous Guest

    This from the Bioreference site:

    Originally Posted by MY CHEMICAL ROADRACE

    WOW!!! Other labs on this site had better pay attention to this too. Pushing needless and more expensive testing is going to come back and bite them big time.